Why the study?
Does diabetes augment vasoconstriction to ET-1 in renal arteries via changes in receptor affinity/subtype or via downstream signaling pathways in STZ-diabetic rats?
Does diabetes augment vasoconstriction to ET-1 in renal arteries via changes in receptor affinity/subtype or via downstream signaling pathways in STZ-diabetic rats?
Diabetes-induced augmented vasoconstriction to ET-1 in rat renal arteries is likely mediated by increased Ca2+ influx and tyrosine kinase activity rather than changes in ET-1 receptor affinity or distribution.
May implicate post-receptor Ca2+ and tyrosine kinase pathways in diabetic renal ET-1 hyperreactivity; leaves open human translation.
Diabetes is associated with increased reactivity of the renal vascular bed to endothelin-1 (ET-1). It has been observed that diabetes is associated with over-expression of ET(A)- and ET(B)-receptors in the rat renal cortex. However it is not known if these receptors are over-expressed in the renal artery. The objectives of this study were to determine changes in ET-1 receptors and signalling pathways in diabetic renal arteries, to determine the relative roles of protein kinase C and tyrosine kinase activation in mediating these responses and to investigate the role of Rho-kinase activity in mediating the vasoconstrictor responses to ET-1. This study was performed on isolated renal artery segments obtained from STZ-diabetic rats. Results from this study showed that the vasoconstrictor response to ET-1 was potentiated in the diabetic renal artery segments compared to the control animals. Using selective ET-1 receptor antagonists, BQ123 and BQ788, the enhanced ET-1-induced vasoconstriction was shown in this study not to be related to changes in receptor affiinity or receptor subtype distribution. However, the augmented vasoconstrictor response to ET-1 in the diabetic renal artery preparations may be related to increased influx of Ca(2+) through L-type channels and also to increased tyrosine kinase activity.
No takes yet. Share an insight, caveat, or question.
Mariam H.M. Yousif (2005) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: